Abeona Therapeutics (ABEO) Cash from Operations (2011 - 2026)
Abeona Therapeutics (ABEO) posted quarterly Cash from Operations of 19804000.0 for Q1 2026, down 7.62% year-over-year from 21437247.53 in Q1 2025, and down 10.31% quarter-over-quarter from 17953000.0 in Q4 2025.
Powered by 
Analysis
Abeona Therapeutics (ABEO) Cash from Operations (2011 - 2026) Analysis & Trends
Abeona Therapeutics' Cash from Operations history runs 16 years deep, the most recent figure standing at 19804000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 7.62% year-over-year to 19804000.0; the TTM figure through Mar 2026 stood at 77728000.0 (down 29.81% YoY), while the FY2025 annual figure was 76326000.0, down 36.26% from the prior year.
- Cash from Operations for Q1 2026 stood at 19804000.0, down from 17953000.0 in the prior quarter.
- The five-year high for Cash from Operations was 5746000.0 in Q3 2023, with the low at 21187000.0 in Q3 2025.
- The 5-year median for Cash from Operations is 13687000.0 (2022), against an average of 13684529.41.
- The sharpest annual moves came in 2022 and 2024: Cash from Operations surged 53.76% in 2022, then plunged 112.91% in 2024.
- Abeona Therapeutics' Cash from Operations stood at 13992000.0 in 2022, then soared by 34.0% to 9235000.0 in 2023, then plunged by 79.31% to 16559000.0 in 2024, then decreased by 8.42% to 17953000.0 in 2025, then fell by 10.31% to 19804000.0 in 2026.
- Business Quant data shows ABEO's Cash from Operations at 19804000.0 in Q1 2026, 17953000.0 in Q4 2025, and 21187000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -526.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -387.32 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 462.82 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 326.72 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 728.46 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Abeona Therapeutics | 342.29 Mn | 195.46 Mn | 7.20 Mn | -17.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17.50 Mn |
| Mar 31, 2026 | -19.80 Mn |
| Dec 31, 2025 | -17.95 Mn |
| Sep 30, 2025 | -21.19 Mn |
| Jun 30, 2025 | -18.78 Mn |
| Mar 31, 2025 | -18.40 Mn |
| Dec 31, 2024 | -16.56 Mn |
| Sep 30, 2024 | -12.23 Mn |
| Jun 30, 2024 | -12.68 Mn |
| Mar 31, 2024 | -14.54 Mn |
| Dec 31, 2023 | -9.24 Mn |
| Sep 30, 2023 | -5.75 Mn |
| Jun 30, 2023 | -10.28 Mn |
| Mar 31, 2023 | -11.74 Mn |
| Dec 31, 2022 | -13.99 Mn |
| Sep 30, 2022 | -6.79 Mn |
| Jun 30, 2022 | -9.01 Mn |
| Mar 31, 2022 | -13.69 Mn |
| Dec 31, 2021 | -30.26 Mn |
| Sep 30, 2021 | -10.33 Mn |